CA Final · Financial Reporting · Ind AS 1 Presentation of Financial Statements
Narmada Foods Ltd approves its financial statements on 20 May. A non-adjusting event occurs on 25 May, before the shareholders' meeting. A director asks which words Ind AS 1 context uses for the approval step in events after the reporting period. Which is correct per the differences from IAS 1?
The Ind AS wording is 'approval of the financial statements for issue'. Ind AS replaces the IAS 1 phrase 'authorisation of the financial statements for issue' with this wording in the context of events after the reporting period.
- A'Authorisation of the financial statements for issue'
- B'Approval of the financial statements for issue'Correct
- C'Ratification of the financial statements by members'
- D'Certification of the financial statements for issue'
Explanation
Appendix 1 states that the words 'approval of the financial statements for issue' are used instead of 'authorisation of the financial statements for issue' in the context of events after the reporting period. The 'authorisation' wording is the IAS 1 term.
Did you get it right without looking?
One question tells you little. A timed set on Ind AS 1 Presentation of Financial Statements shows your real accuracy, how long you take and where you lose marks.
More Ind AS 1 Presentation of Financial Statements questions
- Ganga Pharma Ltd acquired a business in a bargain purchase and, under Ind AS 103, recognised the gain directly in equity as capital reserve.…
- Bharat Pharma Ltd wants to present profit or loss in one statement and a separate, second statement beginning with profit or loss to show ot…
- Meera Steels Ltd acquires a business and recognises a bargain purchase gain under Ind AS 103. The CFO asks where this gain features in the I…
- Sundaram Textiles Ltd is an Ind AS reporting entity. Its finance head proposes to present a separate 'Statement of Profit or Loss' followed …
- Kaveri Engineering Ltd, an Ind AS reporting company, wants to present its profit or loss in one statement and its other comprehensive income…
- Himalaya Pharma Ltd, an Ind AS reporting entity, acquired a business and recognised a bargain purchase gain in equity as capital reserve und…